Skip to main content

Blood Clot clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for
  • A Study of Experimental Apixaban for Venous Thromboembolism (deep vein blood clot) in Children

    open to eligible people ages up to 17 years

    To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.

    at UC Davis UCSF

  • Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

    Sorry, in progress, not accepting new patients

    The overarching objective of the study is to determine the effectiveness of LMWH/ warfarin vs. DOAC anticoagulation for preventing recurrent VTE in cancer patients. The intervention strategy is Direct Oral AntiCoagulants (DOAC) therapy with edoxaban, apixaban, rivaroxaban, or dabigatran. The comparator is low molecular weight heparin (LMWH) alone or with warfarin. The information gained will empower cancer patients and physicians to make more informed choices about anticoagulation strategies to manage VTE.

    at UCSF

Last updated: